ZEAL — Zealand Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK16.22bn
- DKK2.17bn
- DKK9.21bn
Zealand Pharma slump wipes billions off its value after obesity drug data disappoints (updated)
Zealand Pharma slump wipes billions off company value after obesity drug data disappoints
Zealand Pharma tracks worst day ever as obesity drug trial results disappoint
Swiss stocks - Factors to watch on March 6
Brief: Zealand Pharma Announces Positive Phase 2 Results For Petrelintide
Novo Nordisk's $475-billion rise and fall as Wegovy-era gains wiped out (updated)
Novo Nordisk slump wipes out last Wegovy-era gains after trial setback
Novo Nordisk slumps to almost 5-yr lows after obesity drug trial disappoints investors
Brief: Zealand Pharma Fy Revenue Up At DKK 9,215 Million
Brief: Zealand Pharma Announces Positive Phase 1A Topline Results With Kv1.3 Channel Blocker Zp9830
European shares edge higher, buoyed by financials (updated)
European shares edge higher, buoyed by financials
European shares edge up as AI worries ease; InPost rallies (updated)
Novo Nordisk extends gains as Hims abandons $49 weight-loss pill
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk, obesity firms drop on report of Hims Wegovy pill copy launch
Novo Nordisk plunges after shock 2026 forecast
Brief: Zealand Pharma To Use Gefion AI To Accelerate Drug Discovery
Insight: Pills, TikTok and weight-loss apps: the consumer-driven future of GLP-1s